jasbg, I do not want AMRN just for the sake of a sale. I want the right deal for AMRN. AMRN partnered in the US with a Japanese company... I think it cost AMRN more money than it ever brought in. I do not believe in JV's. If a BP can turn Vascepa into a winner at least CVD patients will benefit. AMRN is at a crossroads here, either they sell AMRN to a BP mainly for Europe or they do something else...something stupid would be my guess.